XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Operations Statement - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
REVENUE:    
Services $ 120,936 $ 122,770
Product sales 36,871 30,877
Total revenue 157,807 153,647
OPERATING EXPENSES:    
Cost of services, exclusive of depreciation expense shown below 83,601 85,294
Cost of product sales, exclusive of depreciation expense shown below 30,971 27,520
General and administrative expense, exclusive of depreciation expense shown below 12,756 11,050
Depreciation 6,202 6,627
Amortization 225 220
Other (income) expense, net 873 (4)
OPERATING INCOME 23,179 22,940
Interest expense 2,618 3,434
Income before income tax expense 20,561 19,506
Income tax expense 2,879 4,389
Net income 17,682 15,117
Net income (loss) attributable to non-controlling interest 24 35
Net income attributable to Core Laboratories N.V. $ 17,658 $ 15,082
EARNINGS PER SHARE INFORMATION:    
Basic earnings per share attributable to Core Laboratories N.V. (in dollars per share) $ 0.40 $ 0.36
Diluted earnings per share attributable to Core Laboratories N.V. (in dollars per share) 0.40 0.35
Cash dividends per share (in dollars per share) $ 0.55 $ 0.55
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:    
Basic 44,159 42,380
Diluted 44,347 42,520